Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort study.
Yousery NadaNoha RashadMai EissaAya GhonaimKyrillus FaragIslam SaadawiAhmed ShehaMahmoud El GewaityOmar Abdel-RahmanPublished in: Expert review of gastroenterology & hepatology (2017)
Sorafenib use should be limited to patients with Child A, PS 0-1, and low disease burden.